Abstract:The objective of this study is to analyze clinical manifestations, features of imaging, and laboratory assessment of patients with neuropsychiatric SLE (NPSLE) for better diagnosis and outcome prediction. One hundred eighteen NPSLE patients admitted to the Anhui Provincial Hospital in Hefei, China, between January 2006 and December 2016 were enrolled and analyzed retrospectively. All patients fulfilled the American College of Rheumatology revised classification criteria for SLE. Patients with NPSLE fulfilled the American College of Rheumatology (ACR) nomenclature and case definitions. All NPSLE patients underwent neurological investigations including MRI of nervous system, electroencephalograms, or CSF examination as part of the diagnostic evaluation of nervous system involvement. All statistical analyses were performed. According to different types of data, different statistical methods were used to determine factors associated with abnormal MRI among NPSLE patients. Statistical significance was defined as P value < 0.05(two-tailed). Twelve different neurological manifestations of NPSLE patients were shown, in which headache was most common symptom (25.95%, 34/131), followed by seizures (25.19%, 33/131), cerebrovascular disease (18.32%, 24/131), psychosis (8.40%, 11/131), and others including mood disorder, cognitive dysfunction, plexopathy, cranial neuropathy, movement disorder, myelopathy, acute confusional state, and anxiety disorder. Thirteen patients have two neurological symptoms at the same time. Cerebrospinal fluid was assessed in 76 NPSLE patients, in which 29 patients had higher pressure of cerebrospinal fluid and 66 patients had abnormal immunoglobulin in cerebrospinal fluid, predominantly with an increase of IgG (84.21%, 64/76), followed by an increase of IgA (69.74%, 53/76), and IgM accounted for 47.74% (34/76). The MRI taken by 66.10% (78/118) patients have shown abnormal lesions and/or ischemic changes in the bilateral cerebral hemisphere, thalamus, pons, brainstem, and cerebellum. The abnormal changes in MRI were correlated with antiphospholipid antibody (APL) and C3 (P = 0.026 and 0.040, respectively). The most common clinical manifestation of NPSLE is headache, followed by seizures and cerebrovascular accident. The test of cerebrospinal fluid and MRI plays an important role in the assessment of NPSLE. The abnormal intracranial lesions were correlated with the level of anti-cardiolipin antibodies (ACL) and C3.

Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus

Expression of S100B Protein Levels in Serum and Cerebrospinal Fluid with Different Forms of Neuropsychiatric Systemic Lupus Erythematosus.

IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus

Identify Biomarkers of Neuropsychiatric Systemic Lupus Erythematosus by Matrix-assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Combined with Weak Cation Magnetic Beads

Surrogate biomarkers identification for neuropsychiatric lupus by proteomic fingerprint technology

THU0036 Discriminating Central Nervous System Infection and Neuropsychiatric Involvement in Patients with Systemic Lupus Erythematosus: A Single-Center Experience

Role of IL-1β, IL-6, IL-8 and IFN-γ in pathogenesis of central nervous system neuropsychiatric systemic lupus erythematous.

Novel CSF Biomarkers for Diagnosis and Integrated Analysis of Neuropsychiatric Systemic Lupus Erythematosus: Based on Antibody Profiling.

Increased CCL24 and CXCL7 Levels in the Cerebrospinal Fluid of Patients with Neurosyphilis

Brain Magnetic Resonance Imaging, Cerebrospinal Fluid, and Autoantibody Profile in 118 Patients with Neuropsychiatric Lupus.

The Clinical Significance of Ubiquitin Carboxyl Hydrolase L1 and Its Autoantibody in Neuropsychiatric Systemic Lupus Erythematosus.

Analysis of Cerebrospinal Fluid of Patients with Neuropsychiatric Lupus Erythematosus

332 Cerebrospinal Fluid Ubiquitin Carboxyl Hydrolase L1 (Uch-L1) and Its Autoantibody Are Useful Biomarkers for Neuropsychiatric Systemic Lupus Erythematosus (Npsle)

Elevated Levels of Soluble Fractalkine and Increased Expression of CX3CR1 in Neuropsychiatric Systemic Lupus Erythematosus.

Comparative proteomics analysis of plasma protein in patients with neuropsychiatric systemic lupus erythematosus

Intrathecal Cytokine and Chemokine Profiling in Neuropsychiatric Lupus or Lupus Complicated with Central Nervous System Infection

Performance of Eye Sign Combined with Increased Interleukin-6 in Cerebrospinal Fluid in Patients with Neuropsychiatric Lupus Erythematosus

[Clinical Significance of Neuro-Reactive Autoantibodies in Neuro-Psychiatric Systemic Lupus Erythematosus].

Discriminating Infectious Meningitis Versus Neuropsychiatric Involvement in Patients with Systemic Lupus Erythematosus: a Single-Center Experience

Unlocking the secrets of NPSLE: the role of dendritic cell-secreted CCL2 in blood-brain barrier disruption

Clinical Manifestations Of Neuropsychiatric Systemic Lupus Erythematosus In Chinese Patients